Platelet Category,
Count (x109/L), Total (N) |
Low
< 100 , 94 |
Normal
100-450, 93 |
High
> 450, 86 |
Univariate P score |
| Age, y, median (range) |
66 (14-88) |
68 (23-92) |
66 (36-85) |
<0.001 |
| Female/Male, % |
30/70 |
43/57 |
43/57 |
0.15 |
| Hemoglobin, g/dL, median, (range) |
9.4 (4.2-13.6) |
9.6 (6.2-14.8) |
9.2 (5.2-15.1) |
0.005 |
| Neutrophil count x109/L (range) |
1.1 (0.0-10.1) |
1.8 (0.2-32.9) |
3.6 (0.3-37) |
0.14 |
| Platelet count x109/L (range) |
21 (1-86) |
239 (201-334) |
590 (450-1655) |
0.06 |
| FAB/WHO, N, (%) |
|
|
|
|
| RA |
42 (45) |
34 (37) |
20 (23) |
1.0 |
| RARS |
21 (22) |
27 (29) |
21 (24) |
0.5 |
| RAEB |
11 (11) |
10 (11) |
10 (12) |
< 0.001 |
| RAEB-t |
4 (4) |
4 (4) |
2 (2) |
< 0.009 |
| AML |
3 (3) |
3 (3) |
3 (4) |
0.008 |
| CMML |
3 (3) |
2 (2) |
3 (4) |
0.004 |
| Overlap MPN/MDS |
0 (0) |
0 (0) |
9 (11) |
0.5 |
| Systemic Mastocytosis |
0 (0) |
0 (0) |
1 (1) |
N/A |
| RCMD |
0 (0) |
0 (0) |
2 (2) |
0.2 |
| Other |
5 (5) |
6 (6) |
8 (9) |
0.9 |
| N/A |
5 (5) |
7 (8) |
7 (8) |
0.9 |
| CYTOGENETICS, N, (%)1 |
|
|
|
|
| Good |
46 (49) |
74 (80) |
63 (73) |
1.0 |
| Intermediate |
21 (22) |
12 (13) |
13 (15) |
0.2 |
| Poor |
27 (29) |
7 (7) |
10 (12) |
0.001 |
| IPSS SUBTYPE, N, (%) |
|
|
|
|
| Low |
5 (5) |
46 (49) |
41 (48) |
1.0 |
| Intermediate-1 |
57 (61) |
34 (37) |
35 (41) |
< 0.001 |
| Intermediate-2 |
22 (23) |
9 (10) |
7 (8) |
< 0.001 |
| High |
10 (11) |
4 (4) |
3 (3) |
< 0.001 |
| RACE, N, (%) |
|
|
|
|
| Asian |
1 (1) |
2 (2) |
2 (2) |
0.2 |
| Black |
4 (5) |
3 (3) |
4 (5) |
0.5 |
| Hispanic |
0 (0) |
2 (2) |
1 (1) |
0.3 |
| White |
83 (88) |
78 (84) |
71 (83) |
1.0 |
| Other |
0 (0) |
1 (1) |
2 (2) |
0.4 |
| Unknown |
6 (6) |
7 (8) |
6 (7) |
0.9 |
| SURVIVAL STATUS |
|
|
|
|
| Not Alive |
84 (89) |
71 (76) |
60 (70) |
|
| Alive |
10 (11) |
22 (24) |
26 (30) |
|
1See Supplemental Table 1A for specific cytogenetic abnormalities |
